Kevin Chu
Principal
About
Kevin Chu is a Principal on the healthcare team at F-Prime Capital. Prior to F-Prime Capital, Kevin was an Associate Consultant with IMS Consulting Group in New York, where he advised biopharmaceutical clients on development and commercial strategy across multiple therapeutic areas.
Kevin is currently based in the San Francisco office, and works across the healthcare sub-sectors including Therapeutics, MedTech, and Healthcare IT and Services, and also works closely with Eight Roads Ventures China healthcare team to manage F-Prime’s existing and new investment efforts in China.
-
Adagene (Nasdaq: ADAG) is an antibody discovery and engineering company with proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody. Learn more at www.adagene.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Suzhou, China
-
Year Invested
2011
-
Team
-
-
The company specializes in personalized full-cycle cancer treatments and management, from prevention and early test of symptoms to the adoption of advanced cancer treatment methods. Learn more at www.arion.care.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Beijing, China
-
Year Invested
2019
-
Team
-
-
Avivomed, is a medical device company developing innovative neuromodulation technology to treat large disease populations. Learn more at www.avivomed.com.
-
Category
- MedTech
-
Status
- Private
-
Location
Minneapolis, MN and Ireland
-
Year Invested
2021
-
Team
-
-
b-ONE Ortho Corp. is an emerging orthopedic technology company dedicated to the development of innovative orthopedic healthcare solutions that restore patient mobility and improve surgical outcomes. Every day we are committed to becoming the most credible choice for orthopedic products worldwide. Learn more at http://www.b1.co/.
-
Category
- MedTech
-
Status
- Private
-
Location
Cedar Knolls, NJ
-
Year Invested
2018
-
Team
-
-
Cadence Neuroscience is a medical device company developing new therapies for the treatment of epilepsy and other neurological disorders. The company’s core technology was developed at Mayo Clinic and is under clinical evaluation. Founded in 2017 and headquartered in Redmond, Washington, Cadence is led by seasoned executives with extensive backgrounds in neural implant product development and clinical studies. Learn more: https://www.cadenceneuro.com/
-
Category
- MedTech
-
Status
- Private
-
Location
Redmond, WA
-
Year Invested
2023
-
Team
-
-
Curegenix is a Chinese leader in discovery and development of novel drugs in stem cell related diseases. Learn more at www.curegenix.com.
-
Category
- Therapeutics
-
Status
- Private
-
Location
China
-
Year Invested
2016
-
Team
-
-
Cytek Biosciences Inc. (NASDAQ: CTBK) is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capabilities. Learn more at www.cytekbio.com.
-
Category
- MedTech
-
Status
- Public
-
Location
China
-
Year Invested
2015
-
Team
-
-
Farapulse is a medical device company developing a novel approach to treating a range of arrhythmias using pulsed electric field. Farapulse was acquired by Boston Scientific in 2021.
-
Category
- MedTech
-
Status
- Acquired
-
Location
Menlo Park, CA
-
Year Invested
2015
-
Team
-
-
Gu Sheng Tang (“GST”) is a Guangzhou, China-based healthcare services provider that operates a chain of private clinics specializing in traditional Chinese medicine. Learn more at www.gstzy.cn.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Guangzhou, China
-
Year Invested
2015
-
Team
-
-
Huan Qui Li Kang Technology Co., Ltd. (“HQ”) is an early stage hemostatic product manufacturer in China.
-
Category
- MedTech
-
Status
- Private
-
Location
China
-
Year Invested
2015
-
Team
-
-
Hua Medicine (2552.KHK) is a leading clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Learn more at www.huamedicine.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Shanghai, China
-
Year Invested
2010
-
Team
-
-
KnowYourself is a digital health company that is focused on promoting mental wellness in China.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Beijing, China
-
Year Invested
2021
-
Team
-
-
MDDF is a medical device company focused on the manufacturing, development, and commercialization of high quality, affordably priced cardiovascular and general surgery medical devices for the Chinese market.
-
Category
- MedTech
-
Status
- Private
-
Location
Beijing, China
-
Year Invested
2011
-
Team
-
-
Medbanks (0314:HK) is building a data service platform for oncologists and cancer care centers in China. Learn more at www.medbanks.cn.
-
Category
- Health IT/Services
-
Status
- Public
-
Location
Beijing, China
-
Year Invested
2015
-
Team
-
-
Modis Therapeutics, Inc. was formed in 2016 through a collaboration with academic experts in mitochondrial biology. The company’s lead program (MT1621) is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. Modis Therapeutics is headquartered in Oakland CA, with offices in New York City. Modis was acquired by Zogenix.
-
Category
- Therapeutics
-
Status
- Acquired
-
Location
Oakland, CA
-
Year Invested
2018
-
Team
-
-
OriGynMED is a developer of medical devices designed for women’s health. The company is mainly engaged in developing various gynecology medical devices such as hysterectomy cold knife and functional hysteroscope, enabling client to improve treatment effect. Learn more at www.origynmed.com.
-
Category
- MedTech
-
Status
- Private
-
Location
Hangzhou, China
-
Year Invested
2015
-
Team
-
-
RareCyte offers Precision Biology™ solutions focused on multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics. The Company has deep experience in developing advanced precision life science systems used in cutting-edge labs worldwide. RareCyte customers perform innovative research, bring new therapeutics to market, and perform a wide range of single cell applications in oncology and disease research. Learn more at www.rarecyte.com.
-
Category
- MedTech
-
Status
- Private
-
Location
Seattle, WA
-
Year Invested
2021
-
Team
-
-
REDPINE is a medical technology company that provides complete solutions for medical business. It focuses on the research and development and production of single-use Class III medical devices, initially endoscopes for urology and gynecology. Learn more at en.gzredpine.com.
-
Category
- MedTech
-
Status
- Private
-
Location
Guangdong, China
-
Year Invested
2020
-
Team
-
-
TreeENT is a Hangzhou, China-based operator of private, premium-positioned ambulatory surgery centers (ASCs) focused on high volume, high unmet need, and self-pay surgery markets.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Hangzhou, China
-
Year Invested
2019
-
Team
-
-
Zenflow is a medical device company developing the Spring Implant for patients with benign prostate hyperplasia (BPH). Learn more at www.zenflow.com.
-
Category
- MedTech
-
Status
- Private
-
Location
San Francisco, CA
-
Year Invested
2017
-
Team
-